Matugas, Keisha L.

HRN: 19-01-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2022
CEFOTAXIME 500MG (VIAL)
05/20/2022
05/27/2022
IV
500 Mg
Q8
PCAP C
Waiting Final Action 
05/22/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
05/22/2022
05/28/2022
PO
3.5 Ml
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: